Active LitigationMDL 3140
Depo-Provera Lawsuit Facts
TorHoerman Law is actively accepting claims for the Depo-Provera Lawsuit.
Active Litigation·MDL 3140
TorHoerman Law is actively accepting claims for the Depo-Provera Lawsuit.
The Depo-Provera Meningioma Lawsuit centers on claims that prolonged use of the injectable contraceptive Depo-Provera significantly increases the risk of developing meningioma, a type of brain tumor, and that Pfizer failed to adequately warn patients and healthcare providers about this risk.
Our lawyers are currently accepting new clients for the Depo-Provera Litigation.
On this page, we’ll discuss the basis of the Depo-Provera Meningioma Lawsuit, the evidence linking Depo-Provera use to an increased risk of developing brain tumors, the health effects of brain tumors linked to Depo-Provera injections, who qualifies for the Depo-Provera Brain Tumor Lawsuit, and much more.
The Depo-Provera Lawsuit focuses on allegations that prolonged Depo-Provera use increases the risk of developing intracranial meningiomas, a type of brain tumor that can cause severe neurological complications.
Depo-Provera, a birth control injection containing medroxyprogesterone acetate, has been widely prescribed for decades as a long-term contraceptive, but recent scientific evidence suggests that extended exposure to this synthetic hormone may promote abnormal tumor growth.
A 2024 study published in the British Medical Journal reported that women who used Depo-Provera were at a significantly higher risk of developing meningiomas compared to non-users.
Lawsuits claim that Pfizer, the manufacturer, failed to update U.S. warning labels even after regulatory agencies in Europe and Canada acknowledged the potential risks.
Plaintiffs are seeking financial compensation for medical expenses, lost wages, pain and suffering, and other damages caused by their brain tumor diagnoses.
With cases being filed across the country, attorneys the Depo-Provera MDL has been established to consolidate these lawsuits for more efficient pretrial proceedings.
Women who have been diagnosed with meningioma after using Depo-Provera may be eligible to participate in this litigation.
If you or a loved one developed a brain tumor after receiving this birth control injection, you may be able to file a Depo-Provera Lawsuit and pursue compensation.

Contact TorHoerman Law’s team of Depo-Provera Lawyers today for a free consultation.
Use the chat feature on this page to find out if you’re eligible to file a Depo-Provera Lawsuit instantly.
The Depo-Provera Lawsuit filed in federal court is seeking justice and compensation for Depo-Provera users who developed brain tumors after prolonged use.
The health effects of intracranial meningioma brain tumors can be debilitating, causing significant physical, emotional, and financial hardships.
Many women experience severe headaches, vision problems, cognitive impairments, and neurological deficits that interfere with daily life.
The emotional toll can be overwhelming, as patients struggle with anxiety, depression, and uncertainty about their prognosis.
Treatment often requires invasive brain surgery, radiation therapy, or long-term monitoring, leading to substantial medical costs and lost wages.
For those diagnosed with inoperable tumors, managing chronic symptoms becomes an ongoing battle.
If you’ve developed a brain tumor after taking Depo-Provera, our lawyers can help you.
Reach out today or use the chat feature on this page.
The Depo-Provera Meningioma Lawsuit centers on allegations that prolonged use of the contraceptive injection Depo-Provera, which contains medroxyprogesterone acetate, increases the risk of developing meningiomas—slow-growing brain tumors arising from the meninges.
In October 2024, the first federal lawsuit was filed by a woman who used Depo-Provera between 2005 and 2021 and was subsequently diagnosed with a meningioma.
As more cases emerged, plaintiffs sought consolidation of these lawsuits into a multidistrict litigation (MDL) to streamline pretrial proceedings.
In February 2025, the U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized 27 federal lawsuits into The Depo-Provera Multidistrict Litigation (MDL No. 3140), assigning them to Judge M. Casey Rodgers in the Northern District of Florida.
This MDL aims to efficiently handle the growing number of cases alleging that long-term Depo-Provera usage led to meningioma development.
Plaintiffs claim that Pfizer failed to provide adequate warnings about these risks, despite studies indicating a significant association between the Depo-Provera shot and brain tumors.
Women who have filed federal lawsuits in the Depo-Provera MDL seek compensation for medical expenses, pain and suffering, and other damages, asserting that Pfizer’s negligence in informing users about potential risks has led to severe health consequences.
A significant aspect of these claims involves Depo-SubQ Provera 104, a lower-dose version of the original Depo-Provera formulation.
This alternative contains a reduced concentration of medroxyprogesterone acetate and is administered subcutaneously, potentially offering a safer contraceptive option.

Plaintiffs argue that despite having this safer alternative available, Pfizer did not adequately promote or inform healthcare providers and patients about Depo-SubQ Provera 104.
They contend that the company’s continued emphasis on the higher-dose Depo-Provera formulation, without sufficient disclosure of its associated risks, constitutes negligence.
This underpromotion of the lower-dose option is presented as evidence that Pfizer prioritized its own interests over patient safety.
If you’ve developed a brain tumor after receiving Depo-Provera injections for a prolonged period of time, you may be eligible to file a Depo Provera Lawsuit and seek financial compensation.
Contact our Depo-Provera Lawyers for a free consultation, or use the chat feature on this page to find out if you’re eligible to file a Depo Provera Lawsuit instantly.
Lawsuits involving Depo-Provera use and brain tumors are not a class action lawsuit but are instead being handled as a multidistrict litigation (MDL).
In a class action lawsuit, all plaintiffs are grouped into a single case, and any compensation is divided equally among participants.
However, in an MDL, each person who files a Depo-Provera lawsuit has an individual claim, meaning their compensation depends on the severity of their injuries and other case-specific factors.

This structure allows women who developed meningiomas after using Depo-Provera to present their unique medical history and damages rather than being treated as part of a single group.
If you or a loved one have suffered serious health complications from long-term Depo-Provera use, you may have the right to sue Pfizer individually while benefiting from the efficiency of MDL proceedings.
Depo-Provera Lawsuits are in the early stages, and specific settlement amounts have yet to be determined.
However, lawyers anticipate that individual Depo-Provera settlements could range from $100,000 to $500,000 or more, depending on various factors.

Factors influencing potential Depo-Provera settlements include:
It’s important to note that these figures are projections, and actual settlement amounts will depend on the specifics of each case.
If you or a loved one has developed a brain tumor after using Depo-Provera, consulting with an experienced attorney can provide more personalized information regarding potential compensation.
Recent studies, including a landmark study in the British Medical Journal, have identified a significant association between the use of Depo-Provera, a birth control shot containing medroxyprogesterone acetate, and an increased risk of developing intracranial meningiomas, a type of brain tumor.

Key findings from these studies include:
Pfizer and other manufacturers continue to sell Depo-Provera without updating the U.S. label to warn about the increased risk of brain tumors.
This omission persists despite regulatory actions in other countries acknowledging these risks.
In September 2024, the European Medicines Agency (EMA) recommended adding a warning about the risk of meningioma to the Depo-Provera label in Europe.
Similarly, the Canadian label for Depo-Provera has mentioned meningiomas as a potential post-market adverse drug reaction for nearly a decade.
However, as of March 2025, the U.S. Food and Drug Administration (FDA) has not mandated a similar warning, and Pfizer has not independently updated the U.S. label to reflect these serious risks.

This discrepancy has raised concerns among healthcare professionals and patients about the transparency and safety information provided to U.S. consumers.
The absence of updated warnings in the U.S. has also become a central issue in ongoing lawsuits against Pfizer, with plaintiffs alleging that the company failed to adequately inform users of the potential dangers associated with prolonged Depo-Provera use.
Meningiomas, tumors that form in the membranes surrounding the brain and spinal cord, present significant health risks that can drastically affect a person’s quality of life.
These tumors can cause severe headaches, cognitive impairment, and neurological deficits depending on their size and location.
Many individuals with meningiomas experience worsening symptoms over time, including weight gain, vision problems, and difficulty with coordination.
In some cases, meningiomas can lead to serious complications such as blood clots, seizures, or hormonal disruptions, impacting menstrual periods and overall hormonal balance.
Treatment for these tumors often requires invasive procedures such as brain surgery or radiation, both of which carry their own risks and long-term consequences.

Severe Health Issues Linked to Meningiomas:
Women who have developed intracranial meningioma brain tumors after prolonged use of Depo-Provera may be eligible to file a lawsuit against Pfizer, Pharmacia LLC, and other manufacturers.
The Depo-Provera Lawsuit alleges that Pfizer failed to warn users and healthcare providers about the increased risk of brain tumors linked to long-term use of the contraceptive injection.
If you received multiple Depo-Provera shots and were later diagnosed with a meningioma or other serious brain tumor, you may have a case.
If you believe that prolonged use of Depo-Provera caused your brain tumor, contact our law firm for a free consultation.

Our attorneys will evaluate your medical history, review your records, and determine if you meet the criteria for the Depo-Provera multidistrict litigation (MDL).
Use the chat feature on this page to find out if you qualify for a Depo-Provera case instantly.
Taking legal action can help you seek compensation for medical expenses, lost wages, pain and suffering, and other damages caused by this dangerous drug.
To build a strong Depo-Provera Lawsuit, plaintiffs must provide clear evidence linking their use of the contraceptive injection to the development of a benign brain tumor such as meningioma.
Medical records are crucial in proving a history of long-term Depo-Provera usage and a subsequent brain tumor diagnosis, which are key factors in these legal claims.
Our attorneys will help you gather, review, and organize all necessary evidence to support your case.

Evidence for a Depo Provera Lawsuit may include:
In a Depo-Provera Lawsuit, damages refer to the financial, physical, and emotional losses suffered by individuals who developed brain tumors after prolonged use of the contraceptive injection.
These damages help compensate for medical expenses, lost income, pain and suffering, and other hardships caused by the diagnosis.
Our attorneys will assess your case, calculate potential compensation, and fight for the maximum Depo-Provera settlement available.

Damages in a Depo-Provera Brain Tumor Lawsuit may include:
TorHoerman Law is committed to helping individuals who have developed brain tumors after prolonged use of the Depo-Provera birth control shot.
Our experienced legal team understands the serious health and financial burdens that come with a brain tumor diagnosis, and we are actively investigating claims against Pfizer for failing to warn about these risks.
With a proven track record in pharmaceutical litigation, we are prepared to fight for justice and fair compensation for those affected.
If you or a loved one used Depo-Provera and were later diagnosed with a meningioma or other brain tumor, you may have legal options.
Our firm provides a straightforward, no-obligation consultation to review your case and determine your eligibility for a lawsuit.
We work on a contingency fee basis, meaning you pay nothing unless we win compensation on your behalf.

Contact TorHoerman Law today for a free case evaluation.
Use the chat feature on this page or call us now to get started on your Depo-Provera Lawsuit.
The Depo-Provera Lawsuit alleges that Pfizer and other defendants failed to adequately warn patients and healthcare providers about the potential risk of developing intracranial meningiomas from prolonged use of the birth control shot.
Plaintiffs argue that despite scientific studies linking medroxyprogesterone acetate (the active ingredient in Depo-Provera) to an increased risk of brain tumors, the manufacturers continued to market the contraceptive without appropriate warnings.
The lawsuit includes claims of negligence, strict liability for defective design and failure to warn, breach of warranty, and fraudulent concealment.
Plaintiffs contend that Pfizer prioritized profits over safety by failing to update its U.S. label, despite modifying warnings in Europe and Canada.
The key legal claims in the Depo-Provera Lawsuit include:
If you believe prolonged Depo-Provera use contributed to your brain tumor diagnosis, contact our legal team today for a free case evaluation.
No, Depo-Provera has not been recalled in the United States despite mounting evidence linking the contraceptive injection to an increased risk of intracranial meningiomas.
While some countries, including France, have placed restrictions on long-term use due to safety concerns, Pfizer continues to market Depo-Provera in the U.S. without updating the warning label to include the risk of brain tumors.
While a recall has not yet been issued, growing legal pressure, consumer awareness, and regulatory scrutiny could lead to stronger warnings or market changes in the future.
If you used Depo-Provera and developed a brain tumor, contact our attorneys today to discuss your legal options.
Yes, you may still be eligible to file a Depo-Provera Lawsuit even if you received injections years ago.
Many meningiomas grow slowly and may not be diagnosed until years after exposure to medroxyprogesterone acetate in Depo-Provera.
Additionally, legal doctrines like the discovery rule and fraudulent concealment may extend the statute of limitations if you were unaware of the risks.
If you have been diagnosed with an intracranial meningioma or another brain tumor after prolonged Depo-Provera use, contact our legal team today for a free case evaluation.
There is no class action in the United States for brain tumors linked to Depo-Provera usage.
Instead, these cases have been consolidated into a multidistrict litigation (MDL) to streamline pretrial proceedings.
Initially, plaintiffs’ attorneys advocated for the MDL to be centralized in a California federal court, citing the number of cases filed there and legal considerations related to generic drug manufacturers.
Conversely, Pfizer, the manufacturer of Depo-Provera, preferred the MDL to be located in New York, near its corporate headquarters.
After deliberation, the Judicial Panel on Multidistrict Litigation (JPML) decided to transfer the MDL to the Northern District of Florida, under Judge M. Casey Rodgers, recognizing her experience in managing complex product liability cases.
This strategic consolidation aims to enhance judicial efficiency while preserving the individual nuances of each case.
Pfizer argues that it provided adequate warnings about the risks associated with long-term Depo-Provera use and that the connection between the contraceptive injection and meningioma is not fully proven.
However, women affected by these brain tumors claim that Pfizer failed to update the U.S. label to reflect the serious risks that were acknowledged in Europe and Canada.
Plaintiffs argue that Pfizer had access to decades of scientific research linking medroxyprogesterone acetate to an increased risk of intracranial meningiomas but continued to market the drug without proper warnings.
As more lawsuits move forward, Pfizer will likely face increasing scrutiny over what it knew and when it should have disclosed these risks to patients.
Yes, while Depo-Provera is primarily prescribed as a contraceptive, it has also been used to treat certain medical conditions.
Some healthcare providers have prescribed it to manage uterine fibroids, endometriosis, and other hormone-related disorders.
However, with the recent lawsuits and scientific studies linking long-term Depo-Provera use to an increased risk of meningioma brain tumors, women are reconsidering their birth control options.
Patients who were prescribed Depo-Provera for non-contraceptive reasons may also qualify for legal action if they later developed brain tumors linked to the drug.
If you believe Depo-Provera caused your health issues, contact our firm to explore your legal options.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Depo-Provera Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.